The ICR is a company limited by guarantee, incorporated in 1954. It is also a college of the University of London and adheres to regulations set by the Higher Education Funding Council for England (HEFCE).
The ICR is an exempt charity under the Third Schedule of the Charities Act 2011, with the reference number X90004. The ICR’s objects, powers and framework of governance are set out in its Articles of Association, the current version of which was approved by the Members of the ICR in September 2011.
The overall governing body of the ICR is its Board of Trustees, whose Chairman is Luke Johnson. The ICR’s Trustees are responsible for ensuring it pursues its charitable objects, complies with its constitution and relevant legislation and regulations, applies its resources exclusively to its objects, and enacts cancer research of the highest international standard. The Trustees carry the responsibility of company directors of the ICR.
Professor Paul Workman is Interim Chief Executive of the ICR and responsible to the Board of Trustees for the overall direction of the organisation’s management, research and academic activities, the effective prosecution of its work and for recommending the allocation of resources.
Professor Workman is assisted in his work by the Management Executive, which is responsible for formulating strategies, plans and budgets for approval by the Board of Trustees.